<DOC>
	<DOCNO>NCT00894049</DOCNO>
	<brief_summary>This study prospective comparison 2 popular regimen base reduced intensity non-myeloablative approach define optimal myeloablative and/or immu-nonsuppressive association reduce intensity conditioning ( RIC ) . Flu-Bu-ATG ( Study A ) associate Fludarabine ( 30mg/m²/5 day ) , Oral Busulfan ( 8 mg/kg 2 day ) Thymoglobuline ( 2.5 mg/m²/1day ) . Flu-TBI ( Study B ) consist Fludarabine ( 25mg/m²/ 3 day ) 2 Gy total body irradiation ( TBI ) . A randomization 2 phase study accord methodology develop Liu et al ( Liu , 1993 2001 ) evaluation multiple innovative approach . Primary endpoint one year overall survival ( OS ) . Stopping rule include excessive engraftment failure trans-plant related mortality ratio . Data yearly review independent safety review board ( ISRB ) . Inclusion criteria patient present hematological malignancy , eligible non myeloablative allo stem cell transplantation ( SCT ) , age 18 65 , suitable HLA identical sibling . All patient donor include give write informed consent . Protocol submit accepted ethical committee AFFSSAPS cellular therapy committee ( national agency ) .</brief_summary>
	<brief_title>A Study Comparing Non Myeloablative ( Flu-TBI ) Reduced Intensity ( FLU-BU-ATG ) Conditioning Allogenic Transplantation</brief_title>
	<detailed_description />
	<criteria>hematological malignancy solid tumor , eligible non myeloablative allogenic transplantation , age 18 65 , suitable HLA identical sibling contraindication allogenic transplantation pregnant woman breast feed active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>